Editorial and Medical Review Policy

Clinical content is written by the ACT 2 Health team from published clinical literature, FDA labeling and current professional-society guidance. Writers are not clinicians, and we do not present them as such — which is why the byline on an unreviewed article reads “ACT 2 Health Clinical Team” rather than a physician’s name.

Medical review is performed by a licensed physician on our staff whose credential covers the subject matter. We do not treat review as interchangeable: women’s hormone content is reviewed by a board-certified OB-GYN, and metabolic and longevity content by a physician practicing in that area.

• Benjamin H. Krasne, M.D.

  M.D. · Board-Certified in Anesthesiology (American Board of Anesthesiology)

• Johnathan Chance Miller, M.D.

  M.D. · Holistic & Integrative Medicine

• Vanessa Niles, R.N., M.D., F.A.C.O.G.

  M.D., R.N. · Board-Certified OB-GYN, FACOG

When a page has been reviewed, it carries a visible line naming the reviewing physician and the date, linked to their profile. That line is published only for pages a named physician has actually read and confirmed. If you do not see a review line on a page, it has not yet been reviewed. We would rather you could tell the difference than have every page assert a review that did not happen.

Current status. Physician review is being rolled out across our existing library of 54 clinical pages, and none carries a review line yet. New and substantially revised pages are entering review first.

No dosing information. No doses, frequencies, durations, titration schedules or reconstitution instructions, for any compound, including FDA-approved medications. Dosing is set by your clinician for you, and publishing it invites self-medication.

No efficacy promises or before-and-after framing. We do not guarantee outcomes, and we do not publish comparative outcome figures for compounded medications — trial results belong to the branded product they were generated with and do not carry across.

No medication imagery. We do not show vials, bottles or packaging.

Nothing that implies a product is FDA-approved when it is not. Compounded medications and laboratory-developed tests carry an explicit status disclosure on every page that offers them.

Where evidence is limited, we say so on the page rather than omitting it. Several of our treatments are supported by strong mechanism and thin human outcome data, and the pages for those say exactly that. Where a treatment is unlikely to help someone, we say that too — a page that only argues for its own product is not clinical information.

If you find something inaccurate, out of date or misleading, tell us and we will correct it. Material corrections to clinical content are made promptly and the review date is updated. Write to us via our contact page.

Reviewed clinical pages are re-reviewed at least every 12 months, and sooner when guidance changes materially — a labeling change, a new professional-society position, or a safety communication. The February 2026 removal of the boxed warnings from menopausal hormone therapy is an example of the kind of change that triggers an out-of-cycle review.